Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · IEX Real-Time Price · USD

21.46

-0.32 (-1.47%)

At close: Jul 19, 2024, 4:00 PM

21.27

-0.19 (-0.89%)

Pre-market: Jul 22, 2024, 4:40 AM EDT

Denali Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Revenue	295.39	330.53	108.46	48.66	335.66	26.68	Upgrade
Revenue Growth (YoY)	191.13%	204.74%	122.90%	-85.50%	1158.19%	-79.34%	Upgrade
Gross Profit	295.39	330.53	108.46	48.66	335.66	26.68	Upgrade
Selling, General & Admin	101.45	103.35	90.48	79.06	60.33	46.48	Upgrade
Research & Development	402.08	423.88	358.73	265.35	212.62	193.38	Upgrade
Other Operating Expenses	-14.54	0	0	0	0	0	Upgrade
Operating Expenses	488.99	527.23	449.21	344.41	272.94	239.86	Upgrade
Operating Income	-193.6	-196.7	-340.74	-295.75	62.72	-213.18	Upgrade
Other Expense / Income	-56.38	-51.51	-14.77	-4.6	-9.24	-15.22	Upgrade
Pretax Income	-137.22	-145.19	-325.97	-291.16	71.96	-197.97	Upgrade
Income Tax	0.03	0.03	0.02	-0.58	0.82	-0.35	Upgrade
Net Income	-137.25	-145.22	-325.99	-290.58	71.14	-197.61	Upgrade
Shares Outstanding (Basic)	149	137	126	122	120	96	Upgrade
Shares Outstanding (Diluted)	149	137	126	122	-	96	Upgrade
Shares Change	9.43%	9.43%	3.30%	1.34%	25.43%	3.22%	Upgrade
EPS (Basic)	-0.93	-1.06	-2.60	-2.39	0.65	-2.07	Upgrade
EPS (Diluted)	-0.97	-1.06	-2.60	-2.39	0.63	-2.07	Upgrade
Free Cash Flow	-425.11	-370.93	-262.55	-219.89	413.06	-169.5	Upgrade
Free Cash Flow Per Share	-2.85	-2.70	-2.09	-1.81	3.44	-1.77	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-65.54%	-59.51%	-314.16%	-607.78%	18.69%	-799.10%	Upgrade
Profit Margin	-46.46%	-43.94%	-300.56%	-597.15%	21.19%	-740.74%	Upgrade
Free Cash Flow Margin	-143.92%	-112.22%	-242.06%	-451.88%	123.06%	-635.34%	Upgrade
Effective Tax Rate	-	-	-	-	1.14%	-	Upgrade
EBITDA	-128.37	-128.47	-315.59	-282.56	80.49	-189.97	Upgrade
EBITDA Margin	-43.46%	-38.87%	-290.96%	-580.68%	23.98%	-712.10%	Upgrade
Depreciation & Amortization	8.84	16.73	10.38	8.59	8.53	7.99	Upgrade
EBIT	-137.22	-145.19	-325.97	-291.16	71.96	-197.97	Upgrade
EBIT Margin	-46.45%	-43.93%	-300.54%	-598.34%	21.44%	-742.05%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).